Firstcall Research is bullish on FDC and has recommended buy rating on the stock with a target of Rs 243 in its September 22, 2015 research report.
Firstcall Research's report on FDC
FDC (Foods, Drugs & Chemicals) formerly known as FairDeal Corporation, has been in the pharmaceutical business for more than seven decades now. FDC is a people oriented organization dedicated to innovate,manufacture and market high-quality healthcare products. FDC strives to explore, innovate and integrate solutions with modern technology, empowering talent and expanding healthcare horizons for a better quality of life to millions globally.
We expect that the company surplus scenario is likely to continue for the next three years, will keep its growth story in the coming quarters also. We recommend ‘BUY’ in this particular scrip with a target price ofRs.243.00 for Medium to Long term investment.
For all recommendations, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.